Synthetic Biologics, Inc. (SYN)

Operating Cash Flow (Statement)

-$12.74M

TTM · Period ending: · USD

SYN logo

SYN Operating Cash Flow (Statement)

Latest reported-$12.74M
SYN TTM Cash from Operations (-$1.90M → -$12.74M)
High-resolution chart · PNG

SYN operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Synthetic Biologics, Inc. Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-12,742,000
-14,369,000
-16,669,000
-15,744,000
-17,035,000
-17,337,000
-16,937,000
-19,882,000
-19,082,000
-16,224,000
-14,464,000
-12,890,000
-11,212,000
-11,106,000
-10,536,000
-12,168,000
-12,641,000
-13,653,000
-14,609,000
-13,873,000
-13,558,000
-14,098,000
-15,424,000
-17,279,000
-17,921,000
-18,843,000
-20,275,000
-20,204,000
-26,656,000
-28,115,000
-28,235,000
-27,901,000
-28,487,000
-37,716,000
-39,106,000
-38,890,000
-32,699,000
-22,022,000
-18,067,000
-16,079,000
-14,004,000
-11,189,000
-9,527,000
-7,719,000
-9,788,000
-9,510,000
-9,163,000
-8,916,000
-4,898,860
-4,368,020
-4,032,987
-2,875,000
-2,779,248
-2,764,014
-567,116
-1,139,896
-1,235,296
-1,043,643
-3,181,315
-2,918,864
-2,874,806
-3,189,176
-3,606,697
-4,851,675
-6,367,458
-7,267,975
-6,604,554
-6,606,859
-5,003,650
-3,741,451
-3,661,234
-2,365,819
-2,821,795
-2,164,834
-2,223,823
-1,684,613
-604,613
-784,613
-631,802
-1,020,570
-2,001,171
-4,510,065
-5,824,584
-8,071,533
-9,732,035
-9,144,971
-8,066,923
-6,493,994
-5,148,512
-4,535,825
-5,646,242
-17,646,886
-17,851,265
-16,862,122
-16,143,432
-3,800,000
-4,300,000
-19,300,000
-18,700,000
-18,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.